Ayana Pharma Ltd.

www.ayanapharma.com

Formerly DoxoCure

High-Tech Company

TECH VERTICALS

Life Sciences, MedTech, Pharmaceuticals, Therapeutics

General Data

DESCRIPTION

Ayana Pharma is a pharmaceutical company focused on developing Liposomal Therapeutics for the treatment of cancer.

TECHNOLOGY

Liposome-based Cancer Treatments

Products and Phases

Product	Phase
LC101	FDA Approved
Sterile Doxorubicin-HCI Liposome injection - Providing Therapeutic efficacy with reduced exposure of normal healthy tissues and organs.

	TARGET MARKETS
	Medical Industries, Oncologists, Cancer Patients

	BUSINESS MODEL
	B2C

CONTACT INFO

Expand / Collapse All

Main Address: Jerusalem, Israel

	MANAGEMENT

Key Executive

Name	Title	Previous Position
Prof. Yechezkel Barenholz	CEO & Co-Founder	Capital Nano (Advisory Board Member)
Dr. Dima Shamrakov	Head of R&D
Dr. Avraham Molcho	Co-Founder

	BOARD

Board

	FINANCIAL ROUNDS

Total Capital Raised
abCDe

Financial Rounds

Numbers of Investors

Expand / Collapse All

Round

Date

Stage

Amount

Valuation

Seed

Oct. 01, 2011

Seed

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij*	Angel Club/ Group	abCDe
abC Defghij	Holding Company	abCDe
abC Defghij	Investment Company	abCDe
abC Defghij	Technology Transfer Company	abCDe

Last Updated:	abCDe
IVC Number:	abCDe